Corneal disease is the second most common cause of blindness in the world
1 and occurs often in association with a severely damaged ocular surface.
2 Corneal lesions resulting from dry eye and vascularized corneal scarring caused by different etiologies are not amenable to conventional surgical techniques based on corneal allografting, even if preceded by stem cell transplantation or by the implantation of novel tissue-engineered corneas.
2 Alternative approaches based on the implantation of a synthetic corneal replacement (keratoprosthesis [KPro]) have been proposed for treatment of such diseases. Among the different approaches, one of the oldest, and probably most frequently used since the sixties, is the Strampelli
3 osteo-odonto-keratoprosthesis (OOKP) technique.